Management of T2DM in 2017: Clinically relevant results from cardiovascular outcome trials

Management of T2DM in 2017: Clinically relevant results from cardiovascular outcome trials, Published online: 05 January 2018; doi:10.1038/nrendo.2017.179

The risk of death from cardiovascular causes in people with type 2 diabetes mellitus remains around twice that in the general population, with heart failure a common event. In 2017, results from cardiovascular outcome trials in people with diabetes mellitus showed that some drugs have dual utility — reducing cardiovascular risk and improving glycaemic control.

中文翻译：

---

2017年T2DM的管理：心血管结局试验的临床相关结果

2017年T2DM的管理：心血管结局试验的临床相关结果

2017年T2DM的管理：心血管结局试验的临床相关结果，在线发布：2018年1月5日; doi：10.1038 / nrendo.2017.179

2型糖尿病患者因心血管原因死亡的风险仍然是普通人群的两倍，而心力衰竭是常见的事件。2017年，对糖尿病患者进行的心血管结局试验的结果表明，某些药物具有双重功效-降低心血管风险和改善血糖控制。